Detection of genes responsible for cetuximab sensitization in colorectal cancer cells using CRISPR-Cas9
暂无分享,去创建一个
L. Ye | H. Xue | Ying-ying Chen | Jiawen Yang | You-qun Xiang | Ting Hu | Ye Yan
[1] Jian Yu,et al. MLH1 Deficiency Induces Cetuximab Resistance in Colon Cancer via Her‐2/PI3K/AKT Signaling , 2020, Advanced science.
[2] M. Berchtold,et al. The impact of calmodulin on the cell cycle analyzed in a novel human cellular genetic system. , 2020, Cell calcium.
[3] R. Weinreb,et al. Matrix Metalloproteinases and Glaucoma Treatment , 2020, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.
[4] E. Dekker,et al. Colorectal cancer , 2019, The Lancet.
[5] Kwang-Hyun Cho,et al. Systems analysis identifies potential target genes to overcome cetuximab resistance in colorectal cancer cells , 2019, The FEBS journal.
[6] Y. Xi,et al. MRPL35 Is Up-Regulated in Colorectal Cancer and Regulates Colorectal Cancer Cell Growth and Apoptosis. , 2019, The American journal of pathology.
[7] E. Dronkers,et al. Survival of patients with head and neck cancer with metachronous multiple primary tumors is surprisingly favorable , 2019, Head & neck.
[8] Daniel S. Chertow,et al. CRISPR-Cas Biology and Its Application to Infectious Diseases , 2018, Journal of Clinical Microbiology.
[9] Q. Le,et al. Survival of patients with head and neck cancer treated with definitive radiotherapy and concurrent cisplatin or concurrent cetuximab: A Surveillance, Epidemiology, and End Results‐Medicare analysis , 2018, Cancer.
[10] Xingyu Jiang,et al. The construction of drug-resistant cancer cell lines by CRISPR/Cas9 system for drug screening. , 2018, Science bulletin.
[11] Shukui Wang,et al. Elevated circulating miR-182 acts as a diagnostic biomarker for early colorectal cancer , 2018, Cancer management and research.
[12] Yanmin Zhang,et al. Application of the CRISPR/Cas9 System to Drug Resistance in Breast Cancer , 2018, Advanced science.
[13] Julia M. Shifman,et al. Converting a broad matrix metalloproteinase family inhibitor into a specific inhibitor of MMP-9 and MMP-14 , 2017, bioRxiv.
[14] B. Robert,et al. Inhibition of DDR1‐BCR signalling by nilotinib as a new therapeutic strategy for metastatic colorectal cancer , 2018, EMBO molecular medicine.
[15] Ying Peng,et al. A CRISPR reimagining: New twists and turns of CRISPR beyond the genome‐engineering revolution , 2018, Journal of cellular biochemistry.
[16] Yan Qin,et al. mir-106a regulates cell proliferation and apoptosis of colon cancer cells through targeting the PTEN/PI3K/AKT signaling pathway. , 2017, Oncology letters.
[17] A. Florea,et al. Targeting Intracellular Calcium Signaling ([Ca2+]i) to Overcome Acquired Multidrug Resistance of Cancer Cells: A Mini-Overview , 2017, Cancers.
[18] Wei Shen,et al. MicroRNA-7 functions as a tumor-suppressor gene by regulating ILF2 in pancreatic carcinoma , 2017, International journal of molecular medicine.
[19] V. Gebski,et al. Response to Cetuximab With or Without Irinotecan in Patients With Refractory Metastatic Colorectal Cancer Harboring the KRAS G13D Mutation: Australasian Gastro-Intestinal Trials Group ICECREAM Study. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] Neville E Sanjana,et al. Genome-scale CRISPR-Cas9 knockout and transcriptional activation screening , 2016, Nature Protocols.
[21] D. Neumann,et al. Molecular mechanism of lipid-induced cardiac insulin resistance and contractile dysfunction. , 2016, Prostaglandins, leukotrienes, and essential fatty acids.
[22] C. Blanpain,et al. Cancer Stem Cells: Basic Concepts and Therapeutic Implications. , 2016, Annual review of pathology.
[23] Konstantin Severinov,et al. Kinetics of the CRISPR-Cas9 effector complex assembly and the role of 3′-terminal segment of guide RNA , 2016, Nucleic acids research.
[24] Chih-Yang Huang,et al. Plasma levels of matrix metalloproteinase-2 and -9 in male and female patients with cirrhosis of different aetiologies , 2015, Journal of Clinical Pathology.
[25] Ronald J A Wanders,et al. Isolated mitochondrial long-chain ketoacyl-CoA thiolase deficiency resulting from mutations in the HADHB gene. , 2006, Clinical chemistry.
[26] M. Jamrich,et al. Identification of a human brain-specific gene, calneuron 1, a new member of the calmodulin superfamily. , 2001, Molecular genetics and metabolism.
[27] M. Wheatley,et al. CRISPR/Cas9-Enabled Multiplex Genome Editing and Its Application. , 2017, Progress in molecular biology and translational science.
[28] K. Dede,et al. Pathologic Assessment of Response to Chemotherapy in Colorectal Cancer Liver Metastases after Hepatic Resection: Which Method to Use? , 2014, Pathology & Oncology Research.
[29] Catherine B. Chan,et al. Gene and protein kinase expression profiling of reactive oxygen species-associated lipotoxicity in the pancreatic beta-cell line MIN6. , 2004, Diabetes.